Updates on recent agreements, acquisitions and investments in the pharmaceutical industry.
A review of all cases between 2004 and 2007 admitted to the Aga Khan University Hospital showed that one of 12 infants (8 percent) who additionally received high-dose (2 gram/kg) IVIG died during their hospitalization.
On March 23, 2010, President Barack Obama signed into law the new healthcare reform legislation titled the Affordable Health Care for America Act.
America’s pharmaceutical research and biotechnology companies sent more than $25 million in medicines, medical supplies and cash to Haitian relief efforts after a catostrophic earthquake.
CSL Behring has received Food and Drug Administration approval for its Hizentra immune globulin subcutaneous (human) 20% liquid for treating patients diagnosed with primary immunodeficiency.
The healthcare reform bill meant to increase benefits for the uninsured and underinsured still leaves issues for patients with chronic and rare diseases.
The Alliance for Plasma Therapies received its 501(c)(3) nonprofit status from the Internal Revenue Service inApril 2009.
Octapharma AG recently submitted its biological license application for Octagam 10% (human normal intravenous immunoglobulin, liquid) to the U.S. Food and Drug Administration.
College students with hemophilia or a related bleeding disorder are eligible to apply forthe Eric Dostie Memorial College Scholarship.
The Flu-Free and a Mom-to-Be consumer education campaign received the 2009 Immunization Excellence Award for Best Corporate Campaign at the National Influenza Vaccine Summit’s annual meeting on June 29.
Public health authorities are urging individuals to get the pneumonia vaccine to reduce hospitalizations and deaths associated with the virus.
In 2010, monthly premiums for Medicare beneficiaries who are enrolled in Part D stand-alone prescription drug plans will rise 11 percent on average.